News
Innovative Medicines based on
ImmunoModulatory Biologics
-
Media Room
-
News
IMBiologics, 'OX40LxTNF' biospecific antibody " US FDA IND submission"
-
- Date
- 2023-07-26 14:46:56
-
- View
- 1836
For more information, please visit : IMBiologics News (full article available in Korean)
- President(CEO) : Gyongsik Ha
- 260, Changnyong-daero, Yeongtong-gu, Suwon-si, Gyeonggi-do, Republic of Korea